A randomized controlled trial examining combinations of repaglinide, metformin and NPH insulin
- 24 April 2007
- journal article
- research article
- Published by Wiley in Diabetic Medicine
- Vol. 24 (7), 714-719
- https://doi.org/10.1111/j.1464-5491.2007.02128.x
Abstract
To compare combination use of repaglinide, metformin and bedtime Neutral Protamine Hagedorn (NPH) insulin with conventional approaches of insulin initiation in patients with Type 2 diabetes (T2DM).7507Keywords
This publication has 38 references indexed in Scilit:
- Safety and efficacy of insulin glargine (HOE 901) versus NPH insulin in combination with oral treatment in Type 2 diabetic patientsDiabetic Medicine, 2003
- Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studiesInternational Journal of Obesity, 2000
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Beginning Insulin Treatment of Obese Patients With Evening 70/30 Insulin Plus Glimepiride Versus Insulin AloneDiabetes Care, 1998
- Comparison of Different Insulin Regimens in Elderly Patients With NIDDMDiabetes Care, 1996
- GPOWER: A general power analysis programBehavior Research Methods, Instruments & Computers, 1996
- Bedtime insulin/daytime glipizide. Effective therapy for sulfonylurea failures in NIDDMDiabetes, 1995
- Combined Therapy for Obese Type 2 Diabetes: Suppertime Mixed Insulin with Daytime SulfonylureaThe American Journal of the Medical Sciences, 1992
- Effects of Combination Therapy With Glyburide and Insulin on Serum Lipid Levels in NIDDM Patients With Secondary Sulfonylurea FailureDiabetes Care, 1991
- Efficacy of Bedtime NPH Insulin With Daytime Sulfonylurea for Subpopulation of Type II Diabetic SubjectsDiabetes Care, 1989